Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

Positioning Statements on Physician-led Switching for Biosimilar Medicines

Annual Medicines for Europe and IGBA Conference 2019

15th Legal Affairs Conference

17th Biosimilar Medicines Conference

18th Regulatory and Scientific Affairs Conference

12th Pharmacovigilance Conference

Do you care about patient access? The SPC manufacturing waiver can help!

Switch Management between Similar Biological Medicines. A Communication and Information Guide for Nurses.

Medicines For Europe Country Specific Market Access Policies